Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34121231)

  • 1. Fecal Fusobacterium nucleatum as a predictor for metachronous colorectal adenoma after endoscopic polypectomy.
    Xue JH; Xie YH; Zou TH; Qian Y; Kang ZR; Zhou CB; Pan SY; Xia TX; Chen YX; Fang JY
    J Gastroenterol Hepatol; 2021 Oct; 36(10):2841-2849. PubMed ID: 34121231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a risk score for advanced colorectal adenoma recurrence after endoscopic resection.
    Facciorusso A; Di Maso M; Serviddio G; Vendemiale G; Muscatiello N
    World J Gastroenterol; 2016 Jul; 22(26):6049-56. PubMed ID: 27468196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of colorectal neoplasia after polypectomy: based on initial and consecutive findings.
    van Enckevort CC; de Graaf AP; Hollema H; Sluiter WJ; Kleibeuker JH; Koornstra JJ
    Neth J Med; 2014 Apr; 72(3):139-45. PubMed ID: 24846927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Developing Metachronous Advanced Colorectal Neoplasia After Polypectomy in Patients With Multiple Diminutive or Small Adenomas.
    Kim NH; Jung YS; Lee MY; Park JH; Park DI; Sohn CI
    Am J Gastroenterol; 2019 Oct; 114(10):1657-1664. PubMed ID: 31211708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly sensitive stool DNA testing of Fusobacterium nucleatum as a marker for detection of colorectal tumours in a Japanese population.
    Suehiro Y; Sakai K; Nishioka M; Hashimoto S; Takami T; Higaki S; Shindo Y; Hazama S; Oka M; Nagano H; Sakaida I; Yamasaki T
    Ann Clin Biochem; 2017 Jan; 54(1):86-91. PubMed ID: 27126270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy.
    Martínez ME; Baron JA; Lieberman DA; Schatzkin A; Lanza E; Winawer SJ; Zauber AG; Jiang R; Ahnen DJ; Bond JH; Church TR; Robertson DJ; Smith-Warner SA; Jacobs ET; Alberts DS; Greenberg ER
    Gastroenterology; 2009 Mar; 136(3):832-41. PubMed ID: 19171141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Antibody Responses to Fusobacterium nucleatum and Streptococcus gallolyticus Proteins with Colorectal Adenoma and Colorectal Cancer.
    Genua F; Butt J; Waterboer T; Hughes DJ
    Dig Dis Sci; 2023 Aug; 68(8):3300-3311. PubMed ID: 37338617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence and surveillance of colorectal adenoma after polypectomy in a southern Chinese population.
    Huang Y; Gong W; Su B; Zhi F; Liu S; Bai Y; Jiang B
    J Gastroenterol; 2010 Aug; 45(8):838-45. PubMed ID: 20336471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High incidence of metachronous advanced adenoma and cancer after endoscopic resection of colon polyps ≥20 mm in size.
    Yoshida N; Naito Y; Siah KT; Murakami T; Ogiso K; Hirose R; Inada Y; Inoue K; Konishi H; Kugai M; Morimoto Y; Hasegawa D; Kanemasa K; Wakabayashi N; Yagi N; Yanagisawa A; Itoh Y
    Dig Endosc; 2016 Mar; 28(2):194-202. PubMed ID: 26422700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of advanced metachronous colorectal adenoma during long-term follow-up.
    Nusko G; Hahn EG; Mansmann U
    Int J Colorectal Dis; 2008 Nov; 23(11):1065-71. PubMed ID: 18597098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the risk for metachronous colorectal neoplasms following intestinal polypectomy: a clinical, endoscopic and pathological study.
    Fornasarig M; Valentini M; Poletti M; Carbone A; Bidoli E; Sozzi M; Cannizzaro R
    Hepatogastroenterology; 1998; 45(23):1565-72. PubMed ID: 9840106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal Fusobacterium nucleatum for the diagnosis of colorectal tumor: A systematic review and meta-analysis.
    Zhang X; Zhu X; Cao Y; Fang JY; Hong J; Chen H
    Cancer Med; 2019 Feb; 8(2):480-491. PubMed ID: 30636375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment.
    Yu YN; Yu TC; Zhao HJ; Sun TT; Chen HM; Chen HY; An HF; Weng YR; Yu J; Li M; Qin WX; Ma X; Shen N; Hong J; Fang JY
    Oncotarget; 2015 Oct; 6(31):32013-26. PubMed ID: 26397137